XML 16 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended 6 Months Ended
Jun. 30, 2024
shares
Jun. 30, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

Rule 10b5-1 Trading Plans

On June 21, 2024, Dana Pizzuti, Chief Medical Officer and Chief Development Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 70,000 shares of our common stock until December 31, 2025. None of our officers (as defined in Rule 16a–1(f)) or directors terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each such term is defined in Item 408 of Regulation S-K.

  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Dana Pizzuti [Member]    
Trading Arrangements, by Individual    
Name   Dana Pizzuti
Title Chief Medical Officer and Chief Development Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date June 21, 2024  
Aggregate Available 70,000 70,000